fashion -WSS

fashion

author：comprehensive 2025-09-07 21:55:05 - browse：56823

The FDA building -- First Opinion coverage from STAT — Adobe

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine.

The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators. But in approving the drug for the treatment of fibrodysplasia ossificans progressiva, or FOP, the Food and Drug Administration concluded that Sohonos’ benefits outweigh its risks.

“I just closed my eyes and looked up to the skies, like ‘Thank you, God,’” said Suzanne Hollywood, whose teenage son, Joey, has been receiving the drug in a clinical trial. “It’s far from perfect, but I’m thrilled for my son, for his future, and for the kids getting diagnosed who might not have to experience what others had to.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Congress extends some pandemic preparedness programs

leisure time

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Lawsuit highlights wrinkle for disputes over surprise medical bills

WHO recommends second malaria vaccine

WHO recommends second malaria vaccine

Hospitals are dialing back on venture capital investing

Treatments for cramps don't cut it. Why aren't there better options?

leisure time

fashion

hotspot

In Memoriam: Notable people who died in 2023

Congress extends some pandemic preparedness programs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Novo Nordisk touts Wegovy study, but still struggling with supply

Dobbs anniversary: the lost opportunity of abortion as health care

Lawsuit highlights wrinkle for disputes over surprise medical bills

Affirmative action in medical school literally saved lives

Senators push IRS to launch nonprofit hospital probe

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WHO recommends second malaria vaccine

knowledge

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Stop Congress from blocking public access to science

WHO recommends second malaria vaccine

Aspartame and sugar

What we owe ALS patients — and why one company fell short

leisure time

leisure time

leisure time

entertainment